Back to mobile site

Apricus Biosciences (APRI) Sees Continued Upside On Licensing Deal

December 23, 2010 9:35 AM EST Send to a Friend
Apricus Biosciences (Nasdaq: APRI) is higher again after announcing yesterday afternoon that ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login